Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
338
-
Total 13F shares, excl. options
-
56,253,036
-
Shares change
-
-193,630
-
Total reported value, excl. options
-
$7,906,867,974
-
Value change
-
-$16,787,687
-
Put/Call ratio
-
236%
-
Number of buys
-
155
-
Number of sells
-
-189
-
Price
-
$140.56
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2015
421 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2015.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 338 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,253,036 shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (10,363,098 shares), FMR LLC (9,075,560 shares), VANGUARD GROUP INC (4,114,013 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2,487,288 shares), BlackRock Institutional Trust Company, N.A. (1,490,815 shares), BlackRock Fund Advisors (1,479,891 shares), STATE STREET CORP (1,238,089 shares), JANUS CAPITAL MANAGEMENT LLC (1,204,426 shares), Bank of New York Mellon Corp (1,096,867 shares), and HERNDON CAPITAL MANAGEMENT LLC (984,219 shares).
This table shows the top 338 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.